Chemical compound
Pharmaceutical compound
Abanoquil (INN) is an α1-adrenergic receptor antagonist.[1]
See also
References
- ↑ Tham TC, Guy S, Shanks RG, Harron DW (April 1992). "Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man". British Journal of Clinical Pharmacology. 33 (4): 405–9. doi:10.1111/j.1365-2125.1992.tb04059.x. PMC 1381330. PMID 1349492.
| Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
|---|---|---|---|---|---|
| Other antagonists |
| ||||
| |||||
Urologicals, including antispasmodics (G04B) | |
|---|---|
| Acidifiers | |
| Urinary antispasmodics (primarily antimuscarinics) | |
| Other urologicals | |
| α1 |
| ||||
|---|---|---|---|---|---|
| α2 |
| ||||
| β |
| ||||